TIS 0.00% 0.0¢ tissue therapies limited

double blinded studies, page-15

  1. TDA
    11,411 Posts.
    lightbulb Created with Sketch. 137
    There are a number of wound dressing products that VitroGro would not really replace. The product positioning of VitroGro is to accelerate wound healing while allowing the clinical team to still use their choice of dressing. Although, if VitroGro works really well healing wounds this means that the dressing product(s) are used for a shorter period of time.

    I'm wanting to see them really ramp this up once they can sell, especially the UK and Germany, because they are only going to be accessing around 20% odd of the potential market and it will be years before they enter the US and not until at least Q4 2013 before they enter the other European countries.

 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.